Log in to Congenica
Please select your location and reference genome:
America - GRCh37 America - GRCh38 Europe, Middle East, Africa - GRCh37 Europe, Middle East, Africa - GRCh38

Investors

Driving Precision Medicine

 

Congenica sells mission-critical genomic analysis software and solutions to enterprise customers worldwide. Our world-leading platform is based on pioneering technology from the Wellcome Trust Sanger Institute and the UK NHS, and drives ubiquitous use of complex genetic data for rapid analysis, diagnosis and treatment with the lowest burden on healthcare systems.

 

Download our Corporate Brochure

LEARN MORE ABOUT US

Investing in the future of Precision Medicine

 

 

We work in high-growth genomic segments where automation is crucial to drive market growth.

Our platform is designed to be universal and can be employed in all disease areas where genomic information is crucial to unlock actionable insights

 

Our investors

BGI 240 x 240 Digital Health China 240 x 240 Puhua 240 x 240 legal & general 240 x 240 IDO Investments 240 x 240 Tencent 240 x 240 CIC 240 x 240 Parkwalk 240 x 240 Amadeus 240 x 240 FPC 240 x 240 Xereya Capital 240 x 240 Downing logo 240 x 240

Congenica uniquely understands how to capture genetic sequence data, provide analysis and integrated datasets, and drive precision medicine at scale

Rob Denison CEO Congenica

Our quality assurance 

Regulatory logo banner 960 x 270

Please contact us to request further information

CONTACT US TODAY